AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24401752 — intervention group
Group type: COMPARATOR
Intervention: Standard ORS access
Number of subjects: 3605
Study 23168103 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized Patient (SP) training
Number of subjects: 27
Study 23168103 — intervention group
Group type: COMPARATOR
Intervention: No SP training (Control)
Number of subjects: 27
Study 19965852 — intervention group
Group type: EXPERIMENTAL
Intervention: Small-vessel VaD
Number of subjects: 484
Study 19965852 — intervention group
Group type: EXPERIMENTAL
Intervention: Large-vessel VaD
Number of subjects: 484
Study 18728024 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegfilgrastim
Number of subjects: 0
Study 15811142 — intervention group
Group type: EXPERIMENTAL
Intervention: Orlistat (120 mg three times daily)
Number of subjects: 339
Study 15811142 — intervention group
Group type: COMPARATOR
Intervention: Placebo (three times daily)
Number of subjects: 339
Study 12876240 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon beta-1a (Rebif) treatment
Number of subjects: 38
Study 12876240 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 38
Study 12876240 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (IFNbeta and placebo)
Number of subjects: 38
Study 10390006 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care plus relaxation training and imagery
Number of subjects: 96
Study 10390006 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 96
Study 10390006 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagery ratings
Number of subjects: 96
Study 8529290 — intervention group
Group type: EXPERIMENTAL
Intervention: Tropisetron
Number of subjects: 62
Study 8529290 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide cocktail
Number of subjects: 62
Study 1906432 — intervention group
Group type: EXPERIMENTAL
Intervention: Cibenzoline (260 mg/day and 320 mg/day)
Number of subjects: 31
Study 1906432 — intervention group
Group type: EXPERIMENTAL
Intervention: Flecainide (200 mg/day and 300 mg/day)
Number of subjects: 31
Study 1906432 — intervention group
Group type: EXPERIMENTAL
Intervention: Flecainide (long-term treatment after conversion)
Number of subjects: 31
Study 1906432 — intervention group
Group type: EXPERIMENTAL
Intervention: Cibenzoline (long-term treatment after conversion)
Number of subjects: 31
Study 1906432 — intervention group
Group type: EXPERIMENTAL
Intervention: Cibenzoline and Flecainide
Number of subjects: 31
Study 1906432 — intervention group
Group type: EXPERIMENTAL
Intervention: Flecainide
Number of subjects: 31
Study 31162588 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplements (LNSs) to pregnant women until 6 mo postpartum and child LNSs from 6-24 mo of age (LNS-LNS)
Number of subjects: 4011
Study 31162588 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron and folic acid (IFA) until 3 mo postpartum and child LNSs at 6-24 mo (IFA-LNS)
Number of subjects: 4011
Study 31162588 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron and folic acid (IFA) and child micronutrient powder (MNP) at 6-24 mo (IFA-MNP)
Number of subjects: 4011
Study 31162588 — intervention group
Group type: COMPARATOR
Intervention: Iron and folic acid (IFA) and no child supplement (IFA-Control)
Number of subjects: 4011
Study 29199503 — intervention group
Group type: EXPERIMENTAL
Intervention: SMART Arm with outcome-triggered electrical stimulation and usual therapy
Number of subjects: 50
Study 29199503 — intervention group
Group type: EXPERIMENTAL
Intervention: SMART Arm alone and usual therapy
Number of subjects: 50
Study 29199503 — intervention group
Group type: COMPARATOR
Intervention: usual therapy
Number of subjects: 50
Study 25243819 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic-guidance (LG)
Number of subjects: 40
Study 25243819 — intervention group
Group type: COMPARATOR
Intervention: Skilled instructor (SI)
Number of subjects: 40
Study 24934070 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet soda (200 ml with aspartame and acesulfame potassium)
Number of subjects: 80
Study 24934070 — intervention group
Group type: COMPARATOR
Intervention: Regular soda (200 ml without sweetener)
Number of subjects: 80
Study 21367921 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin (10 and 25 μg melt doses)
Number of subjects: 0
Study 21367921 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin (100 μg melt dose)
Number of subjects: 0
Study 21367921 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin (50-100 μg melt) for men
Number of subjects: 0
Study 21367921 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin (25 μg melt) for women
Number of subjects: 0
Study 20422814 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoietin alpha intravenously
Number of subjects: 60
Study 20422814 — intervention group
Group type: COMPARATOR
Intervention: Epoietin beta intravenously (Control group A)
Number of subjects: 60
Study 20422814 — intervention group
Group type: COMPARATOR
Intervention: Epoietin beta subcutaneously (Control group B)
Number of subjects: 60
Study 17173900 — intervention group
Group type: EXPERIMENTAL
Intervention: Triptorelin and tibolone cotreatment
Number of subjects: 30
Study 17173900 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment specified)
Number of subjects: 30
Study 15058789 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive intervention program targeting general practice staff lasting 21 months
Number of subjects: 62
Study 15058789 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 62
Study 11865169 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroke unit
Number of subjects: 2269
Study 11865169 — intervention group
Group type: COMPARATOR
Intervention: General medical wards
Number of subjects: 2269
Study 9834809 — intervention group
Group type: EXPERIMENTAL
Intervention: Genius thermometer
Number of subjects: 10
Study 9834809 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermoscan thermometer
Number of subjects: 10
Study 9834809 — intervention group
Group type: EXPERIMENTAL
Intervention: Quickthermo thermometer
Number of subjects: 10
Study 9834809 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermopit thermometer
Number of subjects: 10
Study 7666796 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRH1-29NH2 (1 micrograms/kg)
Number of subjects: 15
Study 7666796 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRP-2 (1 microgram/kg)
Number of subjects: 15
Study 7666796 — intervention group
Group type: COMPARATOR
Intervention: GHRH1-29NH2
Number of subjects: 15
Study 7666796 — intervention group
Group type: COMPARATOR
Intervention: GHRP-2
Number of subjects: 15
Study 2774261 — intervention group
Group type: EXPERIMENTAL
Intervention: Active airway humidification using an MR450 Servo airway heater and humidifier set at 37 degrees C (n = 10)
Number of subjects: 27
Study 2774261 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive airway humidification using the Humid‐Vent 1 heat and moisture exchanger (n = 8)
Number of subjects: 27
Study 2774261 — intervention group
Group type: COMPARATOR
Intervention: No airway humidification and heating (control, n = 9)
Number of subjects: 27
Study 773301 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous gentamicin by bolus administration (3 to 5 min)
Number of subjects: 63
Study 773301 — intervention group
Group type: COMPARATOR
Intervention: Slow infusion of gentamicin (2 h)
Number of subjects: 63
Study 31583436 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin 500 mg twice daily with chemotherapy
Number of subjects: 100
Study 31583436 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 100
Study 31583436 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin with chemotherapy
Number of subjects: 100
Study 28183276 — intervention group
Group type: EXPERIMENTAL
Intervention: Peginterferon beta‐1a every 2 weeks
Number of subjects: 0
Study 28183276 — intervention group
Group type: COMPARATOR
Intervention: Delayed treatment
Number of subjects: 0
Study 25454291 — intervention group
Group type: EXPERIMENTAL
Intervention: Tensioned taping applied perpendicular to the UT fibers
Number of subjects: 42
Study 25454291 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-tensioned taping
Number of subjects: 42
Study 25454291 — intervention group
Group type: COMPARATOR
Intervention: No taping
Number of subjects: 42
Study 23726373 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 μg ghrelin
Number of subjects: 14
Study 23726373 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 21366475 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting injectable risperidone (25 to 50 mg every two weeks)
Number of subjects: 369
Study 21366475 — intervention group
Group type: COMPARATOR
Intervention: Oral antipsychotics (psychiatrist's choice)
Number of subjects: 369
Study 21366475 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting injectable risperidone
Number of subjects: 369
Study 19695629 — intervention group
Group type: EXPERIMENTAL
Intervention: Active transcutaneous electrical nerve stimulation for 4 weeks (2 hours daily)
Number of subjects: 27
Study 19695629 — intervention group
Group type: COMPARATOR
Intervention: Sham transcutaneous electrical nerve stimulation for 4 weeks (2 hours daily)
Number of subjects: 27
Study 19695629 — intervention group
Group type: EXPERIMENTAL
Intervention: Active transcutaneous electrical nerve stimulation
Number of subjects: 27
Study 19695629 — intervention group
Group type: COMPARATOR
Intervention: Sham transcutaneous electrical nerve stimulation
Number of subjects: 27
Study 19695629 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation
Number of subjects: 27
Study 16856215 — intervention group
Group type: COMPARATOR
Intervention: Venlafaxine XR
Number of subjects: 93
Study 16856215 — intervention group
Group type: EXPERIMENTAL
Intervention: Reboxetine
Number of subjects: 93
Study 12631158 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional prophylaxis only
Number of subjects: 120
Study 12631158 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep scaling
Number of subjects: 120
Study 12631158 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical periodontal flap surgery and scaling
Number of subjects: 120
Study 12631158 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 120
Study 11208401 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive techniques for saphenous vein harvesting
Number of subjects: 0
Study 11208401 — intervention group
Group type: COMPARATOR
Intervention: Traditional longitudinal incision for saphenous vein harvesting
Number of subjects: 0
Study 9392698 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticlopidine (250 mg twice a day)
Number of subjects: 243
Study 9392698 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 243
Study 8268431 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural morphine
Number of subjects: 45
Study 8268431 — intervention group
Group type: COMPARATOR
Intervention: Intravenous morphine
Number of subjects: 45
Study 8268431 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoanalgesia
Number of subjects: 45
Study 8268431 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrapleural analgesia
Number of subjects: 45
Study 3813145 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg bupivacaine 0.375% without glucose (Group I)
Number of subjects: 60
Study 3813145 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg bupivacaine 0.375% with 2.5% glucose (Group II)
Number of subjects: 60
Study 3813145 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg bupivacaine 0.375% with 7.5% glucose (Group III)
Number of subjects: 60
Study 29738790 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrow- or wide-pulse NMES
Number of subjects: 30
Study 26860217 — intervention group
Group type: EXPERIMENTAL
Intervention: ENABLE early palliative care intervention
Number of subjects: 207
Study 26860217 — intervention group
Group type: COMPARATOR
Intervention: ENABLE delayed palliative care intervention
Number of subjects: 207
Study 24344872 — intervention group
Group type: EXPERIMENTAL
Intervention: T/iDHT/E2 (Testosterone gel with dutasteride)
Number of subjects: 57
Study 24344872 — intervention group
Group type: EXPERIMENTAL
Intervention: T/DHT/E2 (Testosterone gel alone)
Number of subjects: 57
Study 24344872 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study 24344872 — intervention group
Group type: COMPARATOR
Intervention: T/DHT/iE2 (Testosterone gel with anastrazole)
Number of subjects: 57
Study 21503628 — intervention group
Group type: EXPERIMENTAL
Intervention: Forest therapy camp program
Number of subjects: 92
Study 21503628 — intervention group
Group type: COMPARATOR
Intervention: Normal daily routines (Control)
Number of subjects: 92
Study 20110084 — intervention group
Group type: EXPERIMENTAL
Intervention: duloxetine (60 mg/day)
Number of subjects: 250
Study 18757768 — intervention group
Group type: EXPERIMENTAL
Intervention: Major depression
Number of subjects: 281
Study 18757768 — intervention group
Group type: EXPERIMENTAL
Intervention: Minor depression
Number of subjects: 281
Study 16249960 — intervention group
Group type: EXPERIMENTAL
Intervention: Citicoline (1,000 mg/die intramuscularly) for 2 months
Number of subjects: 30
Study 16249960 — intervention group
Group type: EXPERIMENTAL
Intervention: Citicoline (1,000 mg/die intramuscularly) during additional 2-month periods for a total of 16 periods in 8 years
Number of subjects: 30
Study 16249960 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 2 months
Number of subjects: 30
Study 12132610 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc picolinate (29 mg orally by capsule 3 times a day for 3 months)
Number of subjects: 73
Study 12132610 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study 10745565 — intervention group
Group type: EXPERIMENTAL
Intervention: AngioJet therapy
Number of subjects: 0
Study 10745565 — intervention group
Group type: COMPARATOR
Intervention: Urokinase
Number of subjects: 0
Study 7601299 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg oral sumatriptan
Number of subjects: 238
Study 7601299 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 238
Study 2082492 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dipyridamole
Number of subjects: 98
Study 2082492 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral dipyridamole
Number of subjects: 98
Study 2082492 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 98
Study 2082492 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole (oral and intravenous)
Number of subjects: 98
Study 2082492 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole
Number of subjects: 98
Study 7006663 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Number of subjects: 372
Study 7006663 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent melphalan
Number of subjects: 372
Study 7006663 — intervention group
Group type: EXPERIMENTAL
Intervention: Melphalan with prednisone
Number of subjects: 372
Study 7006663 — intervention group
Group type: EXPERIMENTAL
Intervention: Good renal function with haemoglobin above 100 g/l
Number of subjects: 372
Study 7006663 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal function groups (good, intermediate, poor)
Number of subjects: 372
Study 7006663 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemoglobin level at presentation
Number of subjects: 372
Study 31900227 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic radiofrequency ablation (ERFA)
Number of subjects: 60
Study 31900227 — intervention group
Group type: COMPARATOR
Intervention: Traditional percutaneous radiofrequency ablation (Control)
Number of subjects: 60
Study 31584031 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry brushing
Number of subjects: 43
Study 31584031 — intervention group
Group type: COMPARATOR
Intervention: Wet brushing
Number of subjects: 43
Study 30012187 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative adjuvant application of 5-fluorouracil (5-FU) and low-molecular-weight heparin (LMWH) via intraocular infusion during routine pars plana vitrectomy (PPV)
Number of subjects: 560
Study 30012187 — intervention group
Group type: COMPARATOR
Intervention: Placebo: routinely used intraocular infusion with balanced salt solution during routine PPV
Number of subjects: 560
Study 30012187 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative adjuvant application of 5-FU and LMWH
Number of subjects: 560
Study 25662759 — intervention group
Group type: EXPERIMENTAL
Intervention: Marjoram tea
Number of subjects: 25
Study 25662759 — intervention group
Group type: COMPARATOR
Intervention: Placebo tea
Number of subjects: 25
Study 24361739 — intervention group
Group type: EXPERIMENTAL
Intervention: theta transcranial alternating current stimulation (tACS) applied to left parietal and right parietal areas
Number of subjects: 36
Study 24361739 — intervention group
Group type: EXPERIMENTAL
Intervention: theta transcranial alternating current stimulation (tACS) applied to left parietal area
Number of subjects: 36
Study 24361739 — intervention group
Group type: EXPERIMENTAL
Intervention: theta transcranial alternating current stimulation (tACS) applied to right parietal area
Number of subjects: 36
Study 24361739 — intervention group
Group type: COMPARATOR
Intervention: sham tACS
Number of subjects: 36
Study 24361739 — intervention group
Group type: EXPERIMENTAL
Intervention: theta transcranial alternating current stimulation (tACS) applied to left frontal area
Number of subjects: 36
Study 22706833 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-administered cognitive behavioral therapy (T-CBT)
Number of subjects: 325
Study 22706833 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face cognitive behavioral therapy (CBT)
Number of subjects: 325
Study 20157695 — intervention group
Group type: EXPERIMENTAL
Intervention: Framingham risk equations
Number of subjects: 7502
Study 20157695 — intervention group
Group type: EXPERIMENTAL
Intervention: UKPDS risk equations
Number of subjects: 7502
Study 20157695 — intervention group
Group type: EXPERIMENTAL
Intervention: UKPDS and Framingham risk equations
Number of subjects: 7502
Study 17442998 — intervention group
Group type: EXPERIMENTAL
Intervention: Erlotinib (150 mg/d) with cisplatin and gemcitabine
Number of subjects: 1172
Study 17442998 — intervention group
Group type: COMPARATOR
Intervention: Placebo with cisplatin and gemcitabine
Number of subjects: 1172
Study 16082603 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient self-testing (PST) with testing every week
Number of subjects: 400
Study 16082603 — intervention group
Group type: COMPARATOR
Intervention: High quality anticoagulation management (HQACM) with testing every 4 weeks
Number of subjects: 400
Study 11507928 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium hexametaphosphate dentifrice (7%)
Number of subjects: 551
Study 11507928 — intervention group
Group type: COMPARATOR
Intervention: Regular sodium fluoride dentifrice
Number of subjects: 551
Study 11507928 — intervention group
Group type: COMPARATOR
Intervention: Triclosan/copolymer dentifrice
Number of subjects: 551
Study 10633886 — intervention group
Group type: EXPERIMENTAL
Intervention: Enamel matrix proteins (EMD)
Number of subjects: 14
Study 10633886 — intervention group
Group type: COMPARATOR
Intervention: Guided tissue regeneration (GTR)
Number of subjects: 14
Study 8607400 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamins C and E (600 mg/day, orally for 14 days)
Number of subjects: 61
Study 8607400 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment only (control group)
Number of subjects: 61
Study 1663053 — intervention group
Group type: EXPERIMENTAL
Intervention: MgCl2
Number of subjects: 10
Study 1663053 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 microgram/d of 1-alpha (OH)D
Number of subjects: 10
Study 1663053 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined 1-alpha (OH)D and MgCl2
Number of subjects: 10
Study 7165010 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetyl cysteine (NAC) 5.5 gm/m2 daily for 30 days
Number of subjects: 19
Study 7165010 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 19
Study 7165010 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetyl cysteine (NAC)
Number of subjects: 19
Study 30712729 — intervention group
Group type: EXPERIMENTAL
Intervention: MiYoga mindfulness yoga program
Number of subjects: 42
Study 28626020 — intervention group
Group type: EXPERIMENTAL
Intervention: 2000 IU Vitamin D 3 supplementation
Number of subjects: 42
Study 27023825 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous Cortical Bone Trajectory (pCBT)
Number of subjects: 40
Study 27023825 — intervention group
Group type: COMPARATOR
Intervention: Traditional Percutaneous Pedicle Screw (PPS)
Number of subjects: 40
Study 25475489 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based education plus usual care
Number of subjects: 0
Study 25475489 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 23386016 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer‐Assisted Insulin Protocol
Number of subjects: 60
Study 23386016 — intervention group
Group type: COMPARATOR
Intervention: Leuven Protocol
Number of subjects: 60
Study 23386016 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 60
Study 20457167 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg single oral dose of propranolol (beta-noradrenergic antagonist)
Number of subjects: 0
Study 20457167 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0
Study 20457167 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsocial feedback (green vs. red color signals)
Number of subjects: 0
Study 17600459 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus an educational intervention on risk-factor management
Number of subjects: 50
Study 17600459 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 50
Study 15710304 — intervention group
Group type: EXPERIMENTAL
Intervention: Formal Elements Art Therapy Scale task
Number of subjects: 60
Study 15710304 — intervention group
Group type: EXPERIMENTAL
Intervention: Free Drawing
Number of subjects: 60
Study 15710304 — intervention group
Group type: EXPERIMENTAL
Intervention: Outline
Number of subjects: 60
Study 11845369 — intervention group
Group type: EXPERIMENTAL
Intervention: Active (Ga-As) laser treatment
Number of subjects: 40
Study 11845369 — intervention group
Group type: COMPARATOR
Intervention: Placebo laser treatment
Number of subjects: 40